[ASAP] Correction to “Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer”

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.2c00749

16h

[ASAP] Progress and Challenges in Targeting the SARS-CoV‑2 Papain-like Protease

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.2c00303

1d

[ASAP] Structure–Activity Relationships of 8‑Hydroxyquinoline-Derived Mannich Bases with Tertiary Amines Targeting Multidrug-Resistant Cancer

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.2c00076

2d

[ASAP] Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein–Protein Interactions between DOT1L and MLL-AF9/MLL-ENL

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.2c00083

2d

[ASAP] Tuberculosis Drug Discovery: Challenges and New Horizons

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.2c00227

2d

[ASAP] Structure-Aided Design, Synthesis, and Biological Evaluation of Potent and Selective Non-Nucleoside Inhibitors Targeting Protein Arginine Methyltransferase 5

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.2c00398

2d

[ASAP] Optimization of the Natural Product Calothrixin A to Discover Novel Dual Topoisomerase I and II Inhibitors with Improved Anticancer Activity

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.2c00615

2d

[ASAP] Discovery of Novel Bicyclic Phenylselenyl-Containing Hybrids: An Orally Bioavailable, Potential, and Multiacting Class of Estrogen Receptor Modulators against Endocrine-Resistant Breast Cancer

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.2c00525

3d

[ASAP] Discovery of a Novel Series of Imipridone Compounds as <named-content content-type="genus-species" xlink:type="simple">Homo sapiens</named-content> Caseinolytic Protease P Agonists with Potent Antitumor Activities In Vitro and In Vivo

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.1c02071

3d

[ASAP] The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.2c00373

3d